Ginger: Gingerols, Digestive Nutrition & Human Research

This page is part of the AMLApure Ingredient Science Library. It is intended for holistic, integrative, and nutrition-focused healthcare professionals and scientifically interested consumers. Content is educational and does not constitute medical advice.

Ginger: Gingerols, Nutrition & Human Research

What Is Ginger?

Ginger (Zingiber officinale Roscoe) is a flowering plant in the family Zingiberaceae, native to Southeast Asia and now cultivated widely across tropical and subtropical regions including India, China, Nigeria, Jamaica, and Australia. The part of the plant used as a spice, food, and botanical ingredient is the rhizome — the underground stem that grows horizontally, commonly called “ginger root” in culinary and commercial contexts.

Ginger is one of the most widely consumed spices in the world and has an uninterrupted history of use as both a food ingredient and a botanical preparation across South Asian, East Asian, Middle Eastern, and Western herbal medicine traditions spanning more than 2,000 years. It is consumed in multiple forms across food cultures: fresh, dried, pickled, preserved, as a juice, as a tea or infusion, and as a component of complex spice blends.

Culinary Ginger vs. Concentrated Preparations

It is important to distinguish between ginger as it is consumed in food and the concentrated preparations used in nutritional supplement formulations:

  • Fresh ginger rhizome: high water content; contains gingerols as the primary pungent compounds; used in cooking, juicing, and infusions
  • Dried ginger powder: produced by drying and grinding the rhizome; reduced water content concentrates some compounds; a proportion of gingerols convert to shogaols during the drying process
  • Concentrated botanical extracts: produced by extracting and concentrating specific phytochemical fractions; may be standardized to defined percentages of gingerols, total pungent compounds, or other markers; significantly higher phytochemical concentration per gram than whole powder or fresh rhizome

Research findings from studies using one form of ginger do not automatically apply to other forms, and the distinctions between preparations are relevant to interpreting both scientific evidence and supplement formulations.

Naturally Occurring Compounds

Ginger rhizome contains a diverse array of naturally occurring phytochemicals. Its characteristic pungency and aroma derive from several classes of compounds whose relative composition depends on whether the ginger is fresh, dried, or extracted.

Gingerols

Gingerols are the primary pungent compounds in fresh ginger rhizome. They are a family of related phenolic compounds, of which 6-gingerol is the most abundant. Gingerols are thermally labile — they are converted to shogaols and other compounds upon drying, cooking, or prolonged heat exposure. The gingerol content of a preparation therefore depends significantly on whether the source material is fresh or dried and on the processing method used.

Shogaols

Shogaols are dehydration products of gingerols formed during drying and heat processing. 6-shogaol is the most abundant shogaol and is present at substantially higher concentrations in dried ginger powder than in fresh ginger. Shogaols are more pungent than gingerols and have been studied independently in laboratory models. The shogaol-to-gingerol ratio in a preparation reflects its processing history.

Zingerone

Zingerone is produced from gingerols during cooking or heat exposure and contributes to the milder, less pungent character of cooked ginger compared to fresh ginger. It has been studied in some laboratory models but is present at lower concentrations in most supplement preparations.

Paradols

Paradols are a related class of pungent phenolic compounds found in ginger at lower concentrations. They have attracted laboratory research interest but are a minor component of most ginger preparations.

Volatile Oil Constituents

Ginger essential oil — responsible for ginger’s characteristic aroma — contains a range of sesquiterpene and monoterpene compounds including zingiberene, β-bisabolene, ar-curcumene, and others. These volatile compounds contribute to ginger’s sensory and aromatic profile. The essential oil fraction is distinct from the pungent phenolic fraction (gingerols, shogaols) and is not typically the primary focus of metabolic nutrition research.

Other Constituents

Ginger rhizome also contains starch (a significant component by weight in dried powder), dietary fiber, lipids, and smaller amounts of vitamins and minerals. As a food ingredient, its nutritional profile reflects its status as a spice rather than a primary nutrient source.

Research translation note: The presence of bioactive compounds in ginger does not by itself establish that consuming ginger or ginger preparations delivers those compounds to human tissues at clinically relevant concentrations, or that effects observed in laboratory models translate to human clinical outcomes.

Gingerols & Shogaols

Understanding the relationship between gingerols and shogaols is important for interpreting ginger research and supplement formulations.

In fresh ginger, gingerols (particularly 6-gingerol) predominate. When fresh ginger is dried — whether sun-dried, oven-dried, or spray-dried — a proportion of gingerols undergo dehydration reactions to form shogaols. The extent of this conversion depends on drying temperature, duration, and moisture content. Prolonged or higher-temperature drying increases shogaol formation at the expense of gingerols.

This means:

  • A fresh ginger preparation will have a higher gingerol-to-shogaol ratio
  • A dried ginger powder will have a different ratio, with relatively more shogaols
  • A hot-water extract or extract produced under elevated temperatures may have a further altered ratio
  • A standardized extract specifying a percentage of “total gingerols” may define this term to include shogaols or may refer only to gingerols, depending on the supplier’s specification

These distinctions matter when comparing research studies that use different ginger preparations, as the specific compounds present — and their relative concentrations — differ between preparation types.

Neither gingerols nor shogaols have been definitively established as producing specific clinical outcomes in humans through their individual activity. They remain areas of active nutritional and pharmacological research.

Digestive Nutrition

Ginger has one of the most extensive histories of use in digestive nutrition of any botanical ingredient — documented across Ayurvedic, Traditional Chinese Medicine, Greek, Roman, and various folk medicine traditions. Modern nutritional and clinical research has examined several digestive-related applications.

Nausea Research

Ginger has been more extensively studied in human clinical research for nausea-related outcomes than almost any other botanical. Published randomized controlled trials have examined ginger preparations in specific populations including:

  • Pregnancy-related nausea: Multiple RCTs and systematic reviews have examined ginger supplementation in pregnant individuals experiencing nausea and vomiting. A frequently cited 2014 Cochrane review (Matthews et al.) and several meta-analyses concluded that ginger preparations appear to be more effective than placebo for reducing nausea symptoms in pregnancy, with a generally favorable safety profile at studied doses. These findings do not constitute a medical treatment claim; they describe nutritional research outcomes in specific study populations.
  • Chemotherapy-induced nausea: Some RCTs have examined ginger supplementation as an adjunct in chemotherapy patients. Results have been mixed across studies; some trials report modest benefit while others do not. This research is conducted in medical treatment contexts and does not translate to claims for consumer nutritional supplements.
  • Post-operative nausea: A number of trials have examined ginger in post-operative settings with variable results; meta-analyses in this area have reached inconsistent conclusions.

Content boundary: This research is cited for educational context regarding ginger’s research history. AMLApure’s Glycanda™ is a metabolic wellness formulation and does not claim to treat nausea or any digestive disease. Individuals experiencing significant nausea should consult their healthcare provider.

Gastric Motility

Some human studies have examined ginger’s effects on gastric emptying time and gastrointestinal motility. A small number of controlled trials suggest that ginger preparations may influence gastric motility in certain populations, though evidence is limited and study populations vary. This is an area of continued research interest.

Digestive Comfort

Ginger is widely consumed in food and beverage contexts as a digestive spice. Its traditional use as part of post-meal preparations in multiple food cultures reflects its long empirical association with digestive comfort. This traditional use context — while not clinical evidence — is a meaningful part of ginger’s history as a botanical food ingredient.

Antioxidant & Cellular Research

Ginger rhizome extracts and isolated ginger compounds have been extensively studied in laboratory antioxidant and cellular research contexts.

In vitro antioxidant activity: Multiple laboratory assays — including DPPH, ABTS, and FRAP — have reported antioxidant activity for ginger extracts and isolated gingerols and shogaols. This reflects the chemical reactivity of these compounds in controlled laboratory conditions. As with all botanical antioxidant research, in vitro results do not establish equivalent antioxidant effects in human tissues or translate directly to defined human health outcomes.

Cellular and inflammatory pathway research: Laboratory research has examined the effects of ginger compounds on cellular signaling pathways including NF-κB, COX-2, and related inflammatory mediators in cell culture models. These findings are mechanistically interesting but represent early-stage research. Cell culture results cannot be directly extrapolated to clinical anti-inflammatory outcomes in humans consuming ginger supplements.

Animal studies: A substantial volume of animal research has examined ginger and ginger compounds in metabolic, inflammatory, and oxidative stress models. Animal findings provide mechanistic context but have not been consistently replicated in controlled human trials.

This page does not describe laboratory or animal findings as established human health benefits.

Ginger & Metabolic Research

In addition to its digestive research history, ginger has attracted growing research interest in metabolic nutrition contexts — particularly in relation to glucose physiology, lipid metabolism, and body composition. This interest is driven by its phytochemical composition and a growing body of preclinical and human research.

Research areas under investigation include:

  • Effects of ginger supplementation on fasting glucose and insulin sensitivity markers in human trials
  • Effects on lipid profiles (total cholesterol, LDL, HDL, triglycerides) in controlled human studies
  • Proposed mechanisms involving AMPK pathway activity, PPAR-γ effects, and inflammatory mediator modulation in laboratory models
  • Body weight and body composition outcomes in some clinical trials

Structure/function language boundary: Ginger as a botanical ingredient in a nutritional formulation may be discussed in relation to supporting normal metabolic function as part of a balanced diet and healthy lifestyle. This page does not claim that ginger treats, prevents, or cures diabetes, insulin resistance, obesity, dyslipidemia, metabolic syndrome, or any other metabolic disease. These are medical conditions requiring medical management.

What Human Research Shows

Ginger has a comparatively substantial human research base relative to many other botanical ingredients, including a meaningful number of randomized controlled trials and several systematic reviews and meta-analyses. The following is an honest summary of key research areas.

Nausea (Strongest Evidence Area)

As described in the Digestive Nutrition section, ginger’s most consistent and replicated human clinical evidence involves pregnancy-related nausea. Multiple systematic reviews and meta-analyses support a beneficial effect compared to placebo in this population at studied doses. Evidence for chemotherapy-related and post-operative nausea is more mixed.

Metabolic Markers

Human research on ginger and metabolic outcomes has produced mixed results:

  • A 2019 meta-analysis (Maharlouei et al., Critical Reviews in Food Science and Nutrition) examining ginger supplementation and metabolic syndrome parameters reported statistically significant effects on fasting glucose, insulin resistance indices, triglycerides, and LDL cholesterol across pooled trials. However, heterogeneity across studies was substantial, sample sizes in individual trials were generally small, and most studies were conducted in populations with existing metabolic risk factors.
  • A 2018 systematic review on ginger and type 2 diabetes markers (Arablou & Aryaeian) found that some trials reported improvements in glucose-related markers, while methodological limitations including small sample sizes, variable doses, and different ginger preparations limit conclusions.
  • Individual RCTs in this area use variable ginger preparations (powder, extract, standardized extract), doses (typically 1–3g/day of ginger powder), and study durations (8–12 weeks most commonly), making cross-study comparisons difficult.

Inflammatory and Oxidative Stress Markers

Some human trials have examined ginger’s effects on circulating inflammatory biomarkers (CRP, IL-6, TNF-α) and oxidative stress markers. Results are mixed across studies; effect sizes where reported tend to be modest. This research area is promising but not yet conclusive.

Osteoarthritis and Musculoskeletal Research

A notable body of human RCT evidence has examined ginger supplementation in osteoarthritis, particularly knee osteoarthritis. Some trials and a 2015 meta-analysis (Bartels et al., Osteoarthritis and Cartilage) reported that ginger supplementation was associated with modest reductions in pain and disability scores compared to placebo. Effect sizes were generally small to moderate. This research is for educational context and does not constitute a claim for the Glycanda™ formulation.

Honest Summary

Ginger has more human clinical research than many botanical ingredients. Its most consistently supported research area is pregnancy-related nausea. Metabolic research findings are promising but heterogeneous. Evidence across research areas generally reflects small-to-moderate trials with variable preparations and doses. The overall research base does not establish that ginger supplementation reliably treats any metabolic or inflammatory disease in the general population.

Authoritative external resources: Cochrane Library | PubMed — Zingiber officinale human trials | NCCIH — Ginger

Ginger in the Glycanda™ Formulation

Ginger is included as an ingredient in the Glycanda™ Metabolic GLP-1 Support formula — a plant-based powder combining botanical extracts and prebiotic fibers formulated to support metabolic function, digestive balance, and gut microbiome balance.

The full Glycanda™ botanical ingredient blend includes amla, berberine, bitter melon, cinnamon, ginger, inulin, mulberry leaf extract, okra, slippery elm, spearmint, and white kidney bean extract. Ginger is one of several botanicals in the Glycanda™ formula with backgrounds in both digestive and metabolic nutrition research contexts.

Its inclusion in Glycanda™ reflects the formulation’s multi-ingredient botanical approach to metabolic and digestive wellness. AMLApure does not claim that ginger or Glycanda™ treats or prevents any metabolic or digestive disease, lowers blood glucose as a medical therapy, or replaces pharmaceutical management of any condition. AMLApure does not claim clinically proven synergistic outcomes from the combination of ingredients in Glycanda™.

For AMLApure’s broader formulation philosophy and ingredient standards, see The AMLApure Ingredient & Quality Pledge.

Whole Ginger vs. Extract

Fresh Ginger Rhizome

Fresh ginger contains gingerols as its predominant pungent compounds. It is consumed as a food in culinary preparations. The phytochemical concentrations in fresh ginger are lower on a per-gram basis than in dried powder or extracts due to its high water content (approximately 80% water by weight).

Dried Ginger Powder

Drying concentrates the phytochemicals by removing water and partially converts gingerols to shogaols through thermal processing. Standard dried ginger powder is widely used in both culinary and supplement applications. Many clinical studies use defined gram doses of dried ginger powder (typically 1–3g/day).

Standardized Ginger Extracts

Concentrated ginger extracts are produced by extracting specific phytochemical fractions from the rhizome. Commercial ginger extracts may be standardized to a defined percentage of total gingerols, 6-gingerol specifically, or total pungent compounds (gingerols + shogaols combined). Standardized extracts deliver higher concentrations per gram than whole powder and enable more consistent dosing in clinical and supplement contexts.

Research translation caution: A study using 1g/day of dried ginger powder is not equivalent to a study using 250mg of a standardized 20% gingerol extract, even though the mass dose differs dramatically. When evaluating ginger research, the exact preparation, standardization, and dose are material to accurate interpretation. Results from one preparation do not automatically generalize to others.

Quality & Formulation Considerations

Botanical Identity

Zingiber officinale should be confirmed by appropriate botanical identity verification. The genus contains multiple species; ingredient specifications should confirm the correct species. Identity can be confirmed through macroscopic, microscopic, chromatographic (HPLC fingerprinting), or DNA-based methods.

Sourcing and Geographic Origin

Ginger quality can vary by geographic origin, growing conditions, and harvest timing. Key ginger-producing regions including India (particularly Cochin and Malabar origins), China, and Jamaica produce ginger with somewhat different phytochemical profiles and essential oil compositions. Responsible ingredient sourcing includes origin traceability.

Plant Part

The used plant part is the rhizome. Ginger leaf and aerial parts have different phytochemical compositions and are not the basis for supplement ingredient specifications.

Processing and Extraction

Processing conditions — including drying temperature, moisture levels, and extraction solvent — significantly affect the gingerol-to-shogaol ratio and overall phytochemical profile of the finished ingredient. Supercritical CO2 extraction, ethanolic extraction, and aqueous extraction produce different phytochemical fractions with different compositions and concentrations.

Standardization

Commercial standardized ginger extracts may specify total gingerols (sometimes defined to include shogaols), 6-gingerol specifically, or total pungent compounds. Standardization ensures batch consistency. AMLApure’s current published Glycanda™ product information does not specify an extract ratio or standardization percentage for the ginger ingredient; this page therefore does not assert a specific specification beyond what is documented on the product label.

Third-Party Testing

Quality botanical ingredient sourcing includes testing for botanical identity, purity (heavy metals, pesticide residues, microbial contaminants), and composition. Third-party laboratory certificates of analysis are standard quality assurance expectations for responsibly sourced botanical supplement ingredients.

Safety & Considerations

Ginger at culinary food amounts is generally considered very well tolerated and has a long history of safe consumption across global food cultures. Concentrated ginger supplement preparations warrant the following considerations:

Digestive Tolerance

At higher supplement doses, some individuals may experience mild digestive side effects including heartburn, belching, or gastrointestinal discomfort. These are generally dose-dependent and more likely at doses exceeding culinary food amounts. Starting at lower doses and increasing gradually can support digestive tolerance.

Anticoagulant and Antiplatelet Medications

Ginger has demonstrated antiplatelet activity in some laboratory and human studies. Individuals taking anticoagulant medications (such as warfarin, heparin) or antiplatelet medications (such as aspirin, clopidogrel) should consult their prescribing physician or pharmacist before using concentrated ginger supplements. The clinical significance of the interaction at typical supplement doses has not been definitively established, but the theoretical basis warrants caution and professional guidance.

Diabetes Medications

As ginger has been studied in relation to glucose physiology, individuals taking glucose-lowering medications should be aware of this and consult their healthcare provider before using concentrated ginger supplements, particularly if blood glucose is being closely managed.

Pregnancy

Ginger has been studied in clinical trials for pregnancy-related nausea and is generally considered at lower risk than many botanical supplements during pregnancy at studied doses. However, the safety of concentrated ginger extracts during pregnancy has not been established with the same rigor as pharmaceutical agents. Pregnant individuals should consult their obstetrician or midwife before using concentrated ginger supplement preparations, particularly at doses significantly exceeding normal food consumption.

Pre-Surgery

Due to its potential antiplatelet activity, some surgical guidelines recommend discontinuing concentrated ginger supplements 1–2 weeks before elective surgical procedures. Individuals scheduled for surgery should inform their surgical team about all supplements they are taking.

Gallstones

Ginger may stimulate bile production. Individuals with a history of gallstones or bile duct conditions should consult their healthcare provider before using concentrated ginger supplements.

Never modify or discontinue prescribed medical treatment in favor of a dietary supplement without medical supervision.

This educational content is not a substitute for professional medical advice, diagnosis, or treatment.

Frequently Asked Questions

What is ginger?

Ginger (Zingiber officinale) is a tropical plant whose underground rhizome — commonly called the “ginger root” — is used as a culinary spice, food ingredient, and botanical supplement worldwide. It is one of the most widely consumed spices in human history and has been used in traditional botanical medicine across Asian, Middle Eastern, and Western traditions for over two millennia. Its characteristic pungent flavor is due primarily to gingerols (in fresh ginger) and shogaols (formed during drying).

What is Zingiber officinale?

Zingiber officinale Roscoe is the accepted scientific binomial name for ginger, identifying it by genus (Zingiber) and species (officinale) within the family Zingiberaceae. Using the scientific name in supplement labeling and educational content ensures precise botanical identity and distinguishes the culinary ginger species from other members of the ginger family, which includes cardamom, turmeric, and galangal.

What are gingerols?

Gingerols are the primary pungent phenolic compounds in fresh ginger rhizome. They are a family of structurally related compounds, of which 6-gingerol is the most abundant. Gingerols contribute significantly to fresh ginger’s characteristic heat and pungency and are one of the most studied compound classes in ginger nutritional research. Gingerol content decreases when fresh ginger is dried or exposed to sustained heat, as gingerols convert to shogaols through dehydration reactions.

What are shogaols?

Shogaols are dehydration products of gingerols formed during the drying, heat processing, or storage of ginger. 6-shogaol is the most abundant shogaol and is present at substantially higher concentrations in dried ginger powder than in fresh ginger. Shogaols are more intensely pungent than their gingerol precursors and have been studied independently in laboratory models. The relative amounts of gingerols and shogaols in a ginger preparation reflect its processing history and are relevant to comparing research conducted with different ginger preparations.

What is the difference between ginger root and ginger extract?

Ginger root (or dried ginger powder) is the whole rhizome in its minimally processed form — dried and ground. It provides the full phytochemical matrix of the rhizome at its naturally occurring concentrations. A ginger extract is a concentrated preparation produced by extracting and concentrating specific phytochemical fractions. Standardized ginger extracts may specify a defined percentage of total gingerols, 6-gingerol, or total pungent compounds, delivering higher concentrations per gram than whole powder. Research using one form cannot be directly applied to the other without attention to dose equivalence and phytochemical composition.

What does human research on ginger show?

Ginger has a comparatively substantial human clinical research base. Its most consistently supported research area is pregnancy-related nausea, where multiple RCTs and meta-analyses have reported beneficial effects compared to placebo. Research on metabolic markers (glucose, lipids) has produced promising but mixed results across trials with variable preparations and doses. Research on inflammatory biomarkers and osteoarthritis pain has shown some positive signals but overall mixed results. The evidence base does not establish that ginger supplementation reliably treats any specific disease in the general population.

Is ginger used for digestive nutrition?

Yes — ginger has one of the longest and most cross-cultural histories of use in digestive nutrition of any botanical ingredient. Modern human clinical research has examined ginger in relation to nausea, gastric motility, and digestive comfort. The nausea-related research evidence — particularly for pregnancy-related nausea — is among the more consistent in the botanical supplement literature. In nutritional supplement contexts, ginger is included in digestive and metabolic wellness formulations based on this research history and traditional use background. This does not constitute a claim that ginger supplements treat digestive diseases.

Why is ginger included in Glycanda™?

Ginger is listed as an ingredient in Glycanda™ Metabolic GLP-1 Support. Its inclusion reflects Glycanda™’s multi-ingredient botanical approach to metabolic and digestive wellness. Ginger contributes both a digestive nutrition background and a metabolic nutrition research profile to the Glycanda™ formulation — consistent with the formula’s whole-food, plant-based approach. AMLApure does not claim that ginger or Glycanda™ treats any disease or replaces medical management.

Does processing change ginger’s natural compounds?

Yes, significantly. The drying process converts a proportion of gingerols (predominant in fresh ginger) into shogaols through dehydration reactions. The extent of this conversion depends on drying temperature, duration, and moisture. Heat exposure during cooking or extraction further alters the gingerol-to-shogaol ratio and can produce additional conversion products such as zingerone. This means that fresh ginger, dried ginger powder, and different types of ginger extracts have meaningfully different phytochemical compositions, which is relevant when comparing research conducted with different preparations.

Can ginger interact with medications?

Yes — this is an important consideration for some individuals. Ginger has demonstrated antiplatelet activity in laboratory and some human studies, making it a potential concern for individuals taking anticoagulant medications (warfarin, heparin) or antiplatelet agents (aspirin, clopidogrel). Individuals taking glucose-lowering medications should consult their healthcare provider given ginger’s research background in glucose physiology. Individuals scheduled for surgery should inform their surgical team. Always consult a pharmacist or prescribing physician before adding concentrated ginger supplements to a routine that includes prescription medications.

References & Further Reading

  • Matthews A, et al. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015;(9):CD007575. PubMed
  • Maharlouei N, et al. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019;59(11):1753–1766. PubMed
  • Arablou T, Aryaeian N. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. J Complement Integr Med. 2018;15(1). PubMed
  • Bartels EM, et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2015;23(1):13–21. PubMed
  • Lete I, Allue J. The effectiveness of ginger in the prevention of nausea and vomiting during pregnancy and chemotherapy. Integr Med Insights. 2016;11:11–17. PubMed
  • Mashhadi NS, et al. Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity. Int J Prev Med. 2013;4(Suppl 1):S36–S42. PubMed
  • NIH National Center for Complementary and Integrative Health (NCCIH) — Ginger: nccih.nih.gov/health/ginger
  • PubMed: Zingiber officinale human clinical trials

This page is part of the AMLApure Ingredient Science Library. Content is educational and does not constitute medical advice. These statements have not been evaluated by the FDA. AMLApure products are not intended to diagnose, treat, cure, or prevent any disease.